Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in Missouri, automatically classified by Maddy, our AI policy reader.

Total bills
422
2026 Regular Session
Top supporter
-
no data yet
Top opponent
-
no data yet
Ranked legislators
0
0 support · 0 oppose
Showing 281–290 of 422 bills

All healthcare bills

in committee · Missouri · House May 15, 2026

HB 2471: Creates provisions relating to dental plans

HB 2471 requires dental plans to calculate and report a "dental loss ratio," which measures the percentage of premiums spent on actual patient care (not overhead). Dental plans must file annual reports by March 1st detailing this ratio, based on specific formulas that exclude administrative costs and certain fees. If a plan's ratio falls below 85%, it must issue rebates to enrollees by August 1st of the following year, calculated as the difference between premiums and patient care spending. This bill directly affects private dental plans (excluding state programs like MO HealthNet) and their enrollees, mandating transparency and rebates when plans spend too little on care.
in committee · Missouri · Senate Jan 8, 2026

SB 884: Provides that the practice of optometry shall include the use of injectable agents and surgical procedures for certain purposes

SB 884 would expand the scope of practice for optometrists by allowing them to use injectable medications and perform certain minor surgical procedures for specific eye conditions, such as treating dry eyes or removing small growths. This change would directly affect optometrists (eye care providers) and their patients who currently seek these treatments from ophthalmologists. The bill amends the existing optometry practice law to explicitly include these procedures under "certain purposes" defined by the legislation. As a proposed bill (prefiled but not yet enacted), it remains under review by the Senate committee.
in committee · Missouri · House May 15, 2026

HB 2081: Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program

HB 2081 requires Missouri-based entities participating in the federal 340B drug pricing program (which provides discounted medications to safety-net hospitals and clinics) to submit detailed annual reports to the state Department of Health and Senior Services by April 1st. The reports must include specific financial data on drug acquisition costs, payments received, charity care expenses, and how savings from the program are used. Entities failing to submit on time face daily fines of $1,000. The department will then compile and publicly share aggregated data annually, while keeping individual entity reports confidential. This bill directly affects Missouri hospitals, clinics, and outpatient facilities that operate under the federal 340B program.
Sub-Topics Prescription Drugs
in committee · Missouri · Senate Feb 18, 2026

SB 1275: Permits over-the-counter purchase of ivermectin and hydroxycholorquine tablets without a prescription

SB 1275 would allow consumers to purchase ivermectin and hydroxychloroquine tablets directly from pharmacies without needing a doctor's prescription. This change would directly affect patients seeking these medications for approved uses (like treating certain parasitic infections or autoimmune conditions) and pharmacies selling them. The key provision removes the current requirement for a prescription, making these specific medications available over-the-counter.
in committee · Missouri · House May 15, 2026

HB 2313: Prohibits the use of fetal organs or tissue resulting from elective abortions for medical, scientific, research, experimental, or therapeutic purposes or any other use

HB 2313 prohibits using fetal organs or tissue obtained from elective abortions for medical, research, therapeutic, or any other purpose. It bans offering money or incentives to women to conceive or abort specifically to harvest fetal tissue, though it allows payments for burial, medical exams, or pathological examinations of fetal remains. The bill directly affects medical researchers, hospitals, and clinics that might have used such tissue, applying only to patient-choice abortions - not medically necessary procedures. It does not restrict other uses of fetal tissue or impact abortion access generally.
Sub-Topics Women's Health
in committee · Missouri · House May 15, 2026

HB 1810: Specifies that the department of health and senior services shall not deny trauma center status to a hospital based on its distance from another trauma center

HB 1810 prevents Missouri's Department of Health and Senior Services from denying trauma center status to a hospital solely based on its distance from another trauma center. The bill revises state law to explicitly prohibit this distance-based denial when hospitals meet other trauma center criteria. It directly affects hospitals seeking or maintaining trauma center designations, particularly those in rural or underserved areas where proximity to other centers might have been a barrier. The key change removes distance as a factor in the designation process, requiring the department to evaluate hospitals based on established clinical criteria instead.
Sub-Topics Hospitals
in committee · Missouri · House May 15, 2026

HB 2354: Establishes and modifies provisions relating to child abuse or neglect

HB 2354 modifies protective custody procedures for children in suspected abuse or neglect cases. It allows police, law enforcement, or physicians to take children into temporary custody (up to 24 hours) when immediate danger exists, requiring prompt notification to juvenile officers. The bill also establishes a SAFE-CARE network that mandates referrals to specialists for medical conditions mimicking abuse (like rickets, osteogenesis imperfecta, or vitamin D deficiency) during investigations. Parents or guardians can request alternative medical opinions, and the division must provide access to medical records to support these requests.
Sub-Topics Children's Health
in committee · Missouri · House May 15, 2026

HB 1950: Creates provisions relating to maternal care

HB 1950 replaces Missouri's existing maternal care reporting law with new provisions focused on reducing infant mortality. It requires counties to annually report infant deaths to local health agencies, disaggregate data by race/ethnicity, and establish fetal/infant mortality review committees in areas with high death rates (five+ deaths in a year or two consecutive years above the state average). Local health agencies must investigate at least 20% of term infant deaths (or one case if fewer than five deaths occur) with a confidential review process, prohibiting public disclosure of individual cases while allowing statistical reporting. This bill directly affects counties, local health agencies, and medical professionals involved in infant mortality reviews, aiming to identify disparities and improve care through data-driven analysis.
in committee · Missouri · Senate Jan 8, 2026

SB 874: Requires public schools to provide free breakfast and lunch to all students

SB 874 requires all public schools in the state to provide free breakfast and lunch to every student, regardless of family income. This policy change eliminates the current system where eligibility for free or reduced-price meals depends on household financial status. The bill mandates that schools cover these meal costs through state funding, shifting the responsibility from individual families to the public education system. It directly affects all K-12 students attending public schools across the state, ensuring universal access to school meals without income-based barriers.
in committee · Missouri · House Mar 11, 2026

HB 1614: Adds certain 7-OH products to the list of Schedule I controlled substances

HB 1614 adds specific synthetic opioids and certain hallucinogens to the state's Schedule I controlled substances list. The bill explicitly lists over 100 chemical compounds - including fentanyl analogs like acetyl fentanyl, 3-methylfentanyl, and carfentanil derivatives, as well as hallucinogens like DMT and psilocybin - to be prohibited under Schedule I, which defines substances with high abuse potential and no accepted medical use. This directly affects anyone possessing or distributing these listed substances, as they would be treated as illegal under state law. The bill does not alter existing medical exemptions but expands the scope of prohibited substances based on chemical structure and pharmacological profile. The legislation is currently pending in committee, having been prefaced and read for the first time in early 2026.
Sub-Topics Drug Policy
Showing 281 to 290 of 422 bills
Previous 1 28 29 30 43 Next